RECRUITINGOBSERVATIONAL
Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders
About This Trial
The specific aim of this project is to validate clinical tests to be used as outcome measures in studies of mTBI-related vision problems.
Who May Be Eligible (Plain English)
Who May Qualify:
- Diagnosis of mTBI within previous 1 to 6 months
- Distance visual acuity better than or equal to 20/25 in each eye
- Score \>21 on Convergence Insufficiency Symptom Survey
Who Should NOT Join This Trial:
- Diagnosis of moderate or severe TBI; \> 30-min loss of consciousness
- Not wearing required refractive error)
- Disease(s) known to affect oculomotor system (multiple sclerosis, Graves orbitopathy, myasthenia gravis, diabetes mellitus, or Parkinson disease)-Manifest strabismus or intraocular injury (evaluated at vision examination)
- Cognitive delays that may impact testing
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Diagnosis of mTBI within previous 1 to 6 months
* Distance visual acuity better than or equal to 20/25 in each eye
* Score \>21 on Convergence Insufficiency Symptom Survey
Exclusion Criteria:
* Diagnosis of moderate or severe TBI; \> 30-min loss of consciousness
* Not wearing required refractive error)
* Disease(s) known to affect oculomotor system (multiple sclerosis, Graves orbitopathy, myasthenia gravis, diabetes mellitus, or Parkinson disease)-Manifest strabismus or intraocular injury (evaluated at vision examination)
* Cognitive delays that may impact testing
Locations (1)
The Eye Institute
Philadelphia, Pennsylvania, United States